HealthBayer Seeks FDA Approval For Regorafenib As Liver Cancer Treatment German drugmaker Bayer on Monday submitted an sNDA proposal to the FDA for the extension of its drug Regorafenib as a second-line treatment for liver cancer. The drug is currently used to treat colorectal cancer.by Alyssa Navarro
Healthy Living/WellnessFlexion Osteoarthritis Knee Pain Drug Found Effective In Late-Stage Studyby Katrina Pascual
Healthy Living/WellnessFDA Strengthens Rules For Using Mesh Implants In Pelvic Surgeriesby Katrina Pascual
Healthy Living/WellnessFDA Approval Could Make Free Autoimmune Disorder Drug Priceyby Katherine Derla
Healthy Living/WellnessFDA Approves Eli Lilly's Drug Basaglar For Diabetes Treatmentby Katrina Pascual
Healthy Living/WellnessGenetically Engineered Salmon Become First Modified Food Animal Approved For Human Consumptionby Jim Algar